• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Sabra Reports Third Quarter 2025 Results; Updates 2025 Guidance

    11/5/25 4:05:00 PM ET
    $SBRA
    Real Estate Investment Trusts
    Real Estate
    Get the next $SBRA alert in real time by email

    Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced its results of operations for the third quarter of 2025.

    THIRD QUARTER 2025 RESULTS AND RECENT EVENTS

    • Results per diluted common share for the third quarter of 2025 were as follows:
      • Net Income: $0.09
      • FFO: $0.33
      • Normalized FFO: $0.36
      • AFFO: $0.37
      • Normalized AFFO: $0.38
    • EBITDARM Coverage Summary:
      • Skilled Nursing/Transitional Care: 2.35x
      • Senior Housing - Leased: 1.52x
      • Behavioral Health, Specialty Hospitals and Other: 3.90x
    • Same store managed senior housing Cash NOI increased 13.3% on a year-over-year basis. Excluding the 16 properties formerly operated by Holiday that remain in Sabra's same store pool, same store Cash NOI growth was 15.9% on a year-over-year basis.
    • In the third quarter of 2025, Sabra acquired six managed senior housing properties for $217.5 million with an estimated initial cash yield of 7.8%, three of which were acquired through a consolidated joint venture in which Sabra has a 95% equity interest. Additionally, during the quarter, Sabra purchased the operations of four managed senior housing properties previously leased to a tenant under triple-net operating leases for $19.7 million. Subsequent to quarter end, Sabra closed on three additional managed senior housing properties for $124.0 million with an estimated initial cash yield of 7.0%, bringing total investments closed year-to-date to $421.9 million.
    • Sabra has been awarded approximately $120 million of additional senior housing investments with an estimated initial cash yield of nearly 8%. These investments are currently in the Letter of Intent or later stage, and Sabra expects to fund these investments, if consummated, with available liquidity, including proceeds from outstanding forward sales agreements under its at-the-market equity offering program ("ATM program").
    • During the third quarter of 2025, Sabra issued 9.6 million shares in settlement of outstanding forward sale agreements at a weighted average price of $17.26 per share, net of commissions, resulting in net proceeds of $165.0 million. On August 5, 2025, Sabra entered into a new $750 million ATM Program and utilized the forward feature to allow for the sale of up to 3.2 million shares at an initial weighted average price of $18.45 per share, net of commissions.
    • On September 10, 2025, Moody's Ratings ("Moody's") upgraded Sabra's senior unsecured notes rating to "Baa3" from "Ba1" and assigned a "Baa3" issuer rating to Sabra, with a Stable outlook. Moody's cited several key factors supporting the rating upgrade, including the Company's sound operating performance, diversified portfolio, improved net debt to EBITDA and the positive long-term outlook for senior housing.
    • As of September 30, 2025, Net Debt to Adjusted EBITDA was 4.96x.
    • On November 5, 2025, Sabra's Board of Directors declared a quarterly cash dividend of $0.30 per share of common stock. The dividend will be paid on November 28, 2025, to common stockholders of record as of the close of business on November 17, 2025.

    2025 UPDATED GUIDANCE

    Sabra is updating 2025 earnings guidance ranges as follows (attributable to common stockholders, per diluted common share):

    • Net Income: $0.655 - $0.665
    • FFO: $1.465 - $1.475
    • Normalized FFO: $1.455 - $1.465
    • AFFO: $1.455 - $1.465
    • Normalized AFFO: $1.495 - $1.505

    Earnings guidance above assumes:

    • Low-single-digit Cash NOI growth for the triple-net portfolio, ignoring the impact of acquisitions and dispositions
    • Full year average same-store cash NOI growth for the managed senior housing portfolio in the mid-teens
    • General and administrative expenses of approximately $50 million, which includes $11 million of stock-based compensation expense
    • Cash interest expense of approximately $104 million
    • Weighted average share count of approximately 244.7 million and 245.7 million for Normalized FFO and Normalized AFFO, respectively
    • No tenants are placed on cash-basis or moved to accrual-basis for revenue recognition after September 30, 2025
    • Only investments, dispositions, and capital markets activity completed as of the date of this release

    The foregoing guidance ranges reflect management's view of current and future market conditions. There can be no assurance that the Company's actual results will not differ materially from the estimates set forth above. Except as otherwise required by law, the Company assumes no, and hereby disclaims any, obligation to update any of the foregoing guidance ranges as a result of new information or new or future developments.

    Commenting on the third quarter's results, Rick Matros, CEO and Chair, said, "Sabra delivered another strong quarter. Same store managed senior housing NOI growth was solid even considering the transition of the properties formerly operated by Holiday, and importantly, the performance of that group of transition assets improved every month during the quarter. Managed senior housing is growing more quickly than anticipated as a percentage of total NOI, and is now roughly 26%. As a result, we are updating our managed senior housing target concentration from 30% to 40%. Additionally, we now expect that investments for the year will exceed the high end of our previous target, which was $500 million. For Sabra's triple net portfolio, EBITDARM rent coverage hit another post-pandemic high, with healthy coverage across our top ten tenants. Skilled nursing occupancy and skilled mix continue to increase. All in all, our portfolio's progress is exceeding internal expectations."

    LIQUIDITY

    As of September 30, 2025, we had approximately $1.1 billion of liquidity, consisting of unrestricted cash and cash equivalents of $200.6 million, available borrowings under our revolving credit facility of $717.8 million and $157.3 million related to shares outstanding under forward sale agreements under the prior ATM program and ATM program. As of September 30, 2025, we also had $690.9 million available under the ATM program.

    CONFERENCE CALL AND COMPANY INFORMATION

    A conference call with a simultaneous webcast to discuss the 2025 third quarter results will be held on Thursday, November 6, 2025, at 10:00 am Pacific Time. The webcast URL is https://events.q4inc.com/attendee/285294519. The dial-in number for U.S. participants is (888) 880-4448. For participants outside the U.S., the dial-in number is (646) 960-0572. The conference ID number is 1382596. A digital replay of the call will be available on the Company's website at www.sabrahealth.com. The Company's supplemental information package for the third quarter will also be available on the Company's website in the "Investors" section.

    ABOUT SABRA

    As of September 30, 2025, Sabra's investment portfolio included 363 real estate properties held for investment (consisting of (i) 217 skilled nursing/transitional care facilities, (ii) 32 senior housing communities ("senior housing - leased"), (iii) 83 senior housing communities operated by third-party property managers pursuant to property management agreements ("senior housing - managed"), (iv) 16 behavioral health facilities and (v) 15 specialty hospitals and other facilities), 14 investments in loans receivable (consisting of three mortgage loans and 11 other loans), four preferred equity investments and two investments in unconsolidated joint ventures. As of September 30, 2025, Sabra's real estate properties held for investment included 36,998 beds/units, spread across the United States and Canada.

    FORWARD-LOOKING STATEMENTS SAFE HARBOR

    This release contains "forward-looking" statements as defined in the Private Securities Litigation Reform Act of 1995. Any statements that do not relate to historical or current facts or matters are forward-looking statements. These statements may be identified, without limitation, by the use of "expects," "believes," "intends," "should" or comparable terms or the negative thereof. Examples of forward-looking statements include all statements regarding our other expectations regarding our future financial position (including our earnings guidance for 2025, as well as the assumptions set forth therein); our expectations regarding our results of operations, cash flows, liquidity, business strategy, growth opportunities, potential investments and dispositions; our expectations regarding our investment activity, including the expected funding for such investments; and our plans and objectives for future operations and capital raising activity.

    Our actual results may differ materially from those projected or contemplated by our forward-looking statements as a result of various factors, including, among others, the following: the ability to reach a definitive agreement for awarded investments and our ability to close such acquisitions on the expected terms or at all; increased labor costs and labor shortages; increases in market interest rates and inflation; pandemics or epidemics, such as COVID-19, and the related impact on our tenants, borrowers and senior housing - managed communities; operational risks with respect to our senior housing - managed communities; competitive conditions in our industry; the loss of key management personnel; uninsured or underinsured losses affecting our properties; potential impairment charges and adjustments related to the accounting of our assets; the potential variability of our reported rental and related revenues as a result of Accounting Standards Update ("ASU") 2016-02, Leases, as amended by subsequent ASUs; risks associated with our investment in our unconsolidated joint ventures; catastrophic weather and other natural or man-made disasters, the effects of climate change on our properties and a failure to implement sustainable and energy-efficient measures; increased operating costs and competition for our tenants, borrowers and senior housing - managed communities; increased healthcare regulation and enforcement; our tenants' dependency on reimbursement from governmental and other third-party payor programs; the effect of our tenants, operators or borrowers declaring bankruptcy or becoming insolvent; our ability to find replacement tenants and the impact of unforeseen costs in acquiring new properties; the impact of litigation and rising insurance costs on the business of our tenants; the impact of required regulatory approvals of transfers of healthcare properties; environmental compliance costs and liabilities associated with real estate properties we own; our tenants', borrowers' or operators' failure to adhere to applicable privacy and data security laws; a material breach of our or our tenants', borrowers' or operators' information technology; our concentration in the healthcare property sector, particularly in skilled nursing/transitional care facilities and senior housing communities, which makes our profitability more vulnerable to a downturn in a specific sector than if we were investing in multiple industries; the significant amount of and our ability to service our indebtedness; covenants in our debt agreements that may restrict our ability to pay dividends, make investments, incur additional indebtedness and refinance indebtedness on favorable terms; adverse changes in our credit ratings; our ability to make dividend distributions at expected levels; our ability to raise capital through equity and debt financings; changes and uncertainty in macroeconomic conditions and disruptions in the financial markets; risks associated with our ownership of property outside the U.S., including currency fluctuations; the relatively illiquid nature of real estate investments; our ability to maintain our status as a real estate investment trust ("REIT") under the federal tax laws; compliance with REIT requirements and certain tax and tax regulatory matters related to our status as a REIT; changes in tax laws and regulations affecting REITs; the ownership limits and takeover defenses in our governing documents and under Maryland law, which may restrict change of control or business combination opportunities; and the exclusive forum provisions in our bylaws.

    Additional information concerning risks and uncertainties that could affect our business can be found in our filings with the Securities and Exchange Commission (the "SEC"), including in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2024. We do not intend, and we undertake no obligation, to update any forward-looking information to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, unless required by law to do so.

    TENANT AND BORROWER INFORMATION

    This release includes information regarding certain of our tenants that lease properties from us and our borrowers, most of which are not subject to SEC reporting requirements. The information related to our tenants and borrowers that is provided in this release has been provided by, or derived from information provided by, such tenants and borrowers. We have not independently verified this information. We have no reason to believe that such information is inaccurate in any material respect. We are providing this data for informational purposes only.

    NOTE REGARDING NON-GAAP FINANCIAL MEASURES

    This release includes the following financial measures defined as non-GAAP financial measures by the SEC: Net Debt to Adjusted EBITDA, funds from operations ("FFO"), Normalized FFO, Adjusted FFO ("AFFO"), Normalized AFFO, FFO per diluted common share, Normalized FFO per diluted common share, AFFO per diluted common share, Normalized AFFO per diluted common share, net operating income ("NOI") and Cash NOI. These measures may be different than non-GAAP financial measures used by other companies, and the presentation of these measures is not intended to be considered in isolation or as a substitute for financial information prepared and presented in accordance with U.S. generally accepted accounting principles. An explanation of these non-GAAP financial measures is included under "Reporting Definitions" in this release, and reconciliations of these non-GAAP financial measures to the GAAP financial measures we consider most comparable are included on the Investors section of our website at https://ir.sabrahealth.com/investors/financials/quarterly-results.

     

    SABRA HEALTH CARE REIT, INC.

    CONSOLIDATED STATEMENTS OF INCOME

    (dollars in thousands, except per share data)

     

     

    Three Months Ended September 30,

     

    Nine Months Ended September 30,

     

     

    2025

     

     

     

    2024

     

     

     

    2025

     

     

     

    2024

     

    Revenues:

     

     

     

     

     

     

     

    Rental and related revenues (1)

    $

    85,354

     

     

    $

    94,555

     

     

    $

    281,214

     

     

    $

    285,427

     

    Resident fees and services

     

    92,017

     

     

     

    73,746

     

     

     

    248,449

     

     

     

    207,716

     

    Interest and other income

     

    12,666

     

     

     

    9,700

     

     

     

    33,067

     

     

     

    27,746

     

    Total revenues

     

    190,037

     

     

     

    178,001

     

     

     

    562,730

     

     

     

    520,889

     

    Expenses:

     

     

     

     

     

     

     

    Depreciation and amortization

     

    48,511

     

     

     

    42,720

     

     

     

    135,591

     

     

     

    127,315

     

    Interest

     

    28,901

     

     

     

    29,467

     

     

     

    83,549

     

     

     

    87,189

     

    Triple-net portfolio operating expenses

     

    3,708

     

     

     

    4,270

     

     

     

    10,885

     

     

     

    12,992

     

    Senior housing - managed portfolio operating expenses

     

    65,946

     

     

     

    54,234

     

     

     

    179,804

     

     

     

    154,258

     

    General and administrative

     

    12,560

     

     

     

    12,404

     

     

     

    37,802

     

     

     

    37,035

     

    Recovery of loan losses

     

    (240

    )

     

     

    (148

    )

     

     

    (640

    )

     

     

    (446

    )

    Impairment of real estate

     

    2,571

     

     

     

    —

     

     

     

    6,674

     

     

     

    18,472

     

    Total expenses

     

    161,957

     

     

     

    142,947

     

     

     

    453,665

     

     

     

    436,815

     

    Other (expense) income:

     

     

     

     

     

     

     

    Loss on extinguishment of debt

     

    (1,154

    )

     

     

    —

     

     

     

    (1,154

    )

     

     

    —

     

    Other (expense) income

     

    (769

    )

     

     

    —

     

     

     

    13,978

     

     

     

    838

     

    Net (loss) gain on sales of real estate

     

    (4,430

    )

     

     

    (5,745

    )

     

     

    5,544

     

     

     

    (3,969

    )

    Total other (expense) income

     

    (6,353

    )

     

     

    (5,745

    )

     

     

    18,368

     

     

     

    (3,131

    )

    Income before income (loss) from unconsolidated joint ventures and income tax (expense) benefit

     

    21,727

     

     

     

    29,309

     

     

     

    127,433

     

     

     

    80,943

     

    Income (loss) from unconsolidated joint ventures

     

    1,226

     

     

     

    214

     

     

     

    2,276

     

     

     

    (301

    )

    Income tax (expense) benefit

     

    (436

    )

     

     

    265

     

     

     

    (1,346

    )

     

     

    (625

    )

    Net income

     

    22,517

     

     

     

    29,788

     

     

     

    128,363

     

     

     

    80,017

     

    Net loss attributable to noncontrolling interests

     

    21

     

     

     

    —

     

     

     

    21

     

     

     

    —

     

    Net income attributable to Sabra Health Care REIT, Inc.

    $

    22,538

     

     

    $

    29,788

     

     

    $

    128,384

     

     

    $

    80,017

     

     

     

     

     

     

     

     

     

    Net income attributable to Sabra Health Care REIT, Inc., per:

     

     

     

     

     

     

    Basic common share

    $

    0.09

     

     

    $

    0.13

     

     

    $

    0.54

     

     

    $

    0.34

     

    Diluted common share

    $

    0.09

     

     

    $

    0.13

     

     

    $

    0.53

     

     

    $

    0.34

     

     

     

     

     

     

     

     

     

    Weighted average number of common shares outstanding, basic

     

    239,896,059

     

     

     

    234,290,187

     

     

     

    238,595,147

     

     

     

    232,459,388

     

    Weighted average number of common shares outstanding, diluted

     

    243,558,449

     

     

     

    237,043,400

     

     

     

    241,593,992

     

     

     

    234,777,101

     

    (1)

    See the following page for additional details regarding rental and related revenues.

    SABRA HEALTH CARE REIT, INC.

    CONSOLIDATED STATEMENTS OF INCOME - SUPPLEMENTAL INFORMATION

    (in thousands)

     

     

    Three Months Ended September 30,

     

    Nine Months Ended September 30,

     

     

    2025

     

     

     

    2024

     

     

     

    2025

     

     

     

    2024

     

    Cash rental income

    $

    88,946

     

     

    $

    91,829

     

     

    $

    271,414

     

     

    $

    273,955

     

    Straight-line rental income

     

    1,027

     

     

     

    1,119

     

     

     

    3,683

     

     

     

    3,383

     

    Write-offs of cash and straight-line rental income receivable and lease intangibles

     

    (9,237

    )

     

     

    (3,086

    )

     

     

    (7,759

    )

     

     

    (5,539

    )

    Above/below market lease amortization

     

    1,058

     

     

     

    1,212

     

     

     

    3,256

     

     

     

    3,634

     

    Operating expense recoveries

     

    3,560

     

     

     

    3,481

     

     

     

    10,620

     

     

     

    9,994

     

    Rental and related revenues

    $

    85,354

     

     

    $

    94,555

     

     

    $

    281,214

     

     

    $

    285,427

     

     

    SABRA HEALTH CARE REIT, INC.

    CONSOLIDATED BALANCE SHEETS

    (dollars in thousands, except per share data)

     

     

    September 30, 2025

     

    December 31, 2024

    Assets

     

     

     

    Real estate investments, net of accumulated depreciation of $1,214,938 and $1,102,030 as of September 30, 2025 and December 31, 2024, respectively

    $

    4,629,842

     

     

    $

    4,513,734

     

    Loans receivable and other investments, net

     

    436,526

     

     

     

    442,584

     

    Investment in unconsolidated joint ventures

     

    117,856

     

     

     

    121,803

     

    Cash and cash equivalents

     

    200,602

     

     

     

    60,468

     

    Restricted cash

     

    6,916

     

     

     

    5,871

     

    Lease intangible assets, net

     

    59,808

     

     

     

    27,464

     

    Accounts receivable, prepaid expenses and other assets, net

     

    113,223

     

     

     

    131,755

     

    Total assets

    $

    5,564,773

     

     

    $

    5,303,679

     

    Liabilities

     

     

     

    Secured debt, net

    $

    43,790

     

     

    $

    45,316

     

    Revolving credit facility

     

    282,213

     

     

     

    106,554

     

    Term loans, net

     

    1,030,058

     

     

     

    529,753

     

    Senior unsecured notes, net

     

    1,235,129

     

     

     

    1,736,025

     

    Accounts payable and accrued liabilities

     

    124,042

     

     

     

    117,896

     

    Lease intangible liabilities, net

     

    22,588

     

     

     

    26,847

     

    Total liabilities

     

    2,737,820

     

     

     

    2,562,391

     

    Equity

     

     

     

    Preferred stock, $0.01 par value; 10,000,000 shares authorized, zero shares issued and outstanding as of September 30, 2025 and December 31, 2024

     

    —

     

     

     

    —

     

    Common stock, $0.01 par value; 500,000,000 shares authorized, 249,349,673 and 237,586,882 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively

     

    2,493

     

     

     

    2,376

     

    Additional paid-in capital

     

    4,792,753

     

     

     

    4,592,605

     

    Cumulative distributions in excess of net income

     

    (1,964,336

    )

     

     

    (1,874,633

    )

    Accumulated other comprehensive (loss) income

     

    (5,976

    )

     

     

    20,940

     

    Total Sabra Health Care REIT, Inc. stockholders' equity

     

    2,824,934

     

     

     

    2,741,288

     

    Noncontrolling interests

     

    2,019

     

     

     

    —

     

    Total equity

     

    2,826,953

     

     

     

    2,741,288

     

    Total liabilities and equity

    $

    5,564,773

     

     

    $

    5,303,679

     

     

    SABRA HEALTH CARE REIT, INC.

    CONSOLIDATED STATEMENTS OF CASH FLOWS

    (in thousands)

     

     

    Nine Months Ended September 30,

     

     

    2025

     

     

     

    2024

     

    Cash flows from operating activities:

     

     

     

    Net income

    $

    128,363

     

     

    $

    80,017

     

    Adjustments to reconcile net income to net cash provided by operating activities:

     

     

     

    Depreciation and amortization

     

    135,591

     

     

     

    127,315

     

    Non-cash rental and related revenues

     

    820

     

     

     

    (2,229

    )

    Non-cash interest income

     

    7

     

     

     

    24

     

    Non-cash interest expense

     

    5,608

     

     

     

    8,750

     

    Stock-based compensation expense

     

    8,290

     

     

     

    6,448

     

    Loss on extinguishment of debt

     

    1,154

     

     

     

    —

     

    Recovery of loan losses

     

    (640

    )

     

     

    (446

    )

    Net (gain) loss on sales of real estate

     

    (5,544

    )

     

     

    3,969

     

    Impairment of real estate

     

    6,674

     

     

     

    18,472

     

    (Income) loss from unconsolidated joint ventures

     

    (2,276

    )

     

     

    301

     

    Distributions of earnings from unconsolidated joint ventures

     

    5,917

     

     

     

    3,754

     

    Other non-cash items

     

    (17,190

    )

     

     

    —

     

    Changes in operating assets and liabilities:

     

     

     

    Accounts receivable, prepaid expenses and other assets, net

     

    (9,129

    )

     

     

    (13,589

    )

    Accounts payable and accrued liabilities

     

    3,541

     

     

     

    (2,213

    )

    Net cash provided by operating activities

     

    261,186

     

     

     

    230,573

     

    Cash flows from investing activities:

     

     

     

    Acquisition of real estate and lease intangibles

     

    (301,563

    )

     

     

    (112,225

    )

    Origination and fundings of loans receivable

     

    (5,710

    )

     

     

    (21,540

    )

    Origination and fundings of preferred equity investments

     

    (9

    )

     

     

    (2,529

    )

    Additions to real estate

     

    (24,183

    )

     

     

    (39,189

    )

    Escrow deposits for potential investments

     

    (500

    )

     

     

    —

     

    Repayments of loans receivable

     

    15,442

     

     

     

    2,776

     

    Repayments of preferred equity investments

     

    1,977

     

     

     

    5,322

     

    Investment in unconsolidated joint ventures

     

    (1,241

    )

     

     

    (717

    )

    Net proceeds from the sales of real estate

     

    43,087

     

     

     

    40,541

     

    Proceeds from net investment hedges

     

    4,462

     

     

     

    —

     

    Insurance proceeds

     

    1,267

     

     

     

    —

     

    Distributions in excess of earnings from unconsolidated joint ventures

     

    5,557

     

     

     

    —

     

    Net cash used in investing activities

     

    (261,414

    )

     

     

    (127,561

    )

    Cash flows from financing activities:

     

     

     

    Net borrowings from revolving credit facility

     

    174,805

     

     

     

    58,815

     

    Principal payments on senior unsecured notes

     

    (500,000

    )

     

     

    —

     

    Proceeds from term loans

     

    500,000

     

     

     

    —

     

    Principal payments on secured debt

     

    (1,562

    )

     

     

    (1,520

    )

    Payments of deferred financing costs

     

    (4,405

    )

     

     

    (80

    )

    Payments related to extinguishment of debt

     

    (2,884

    )

     

     

    —

     

    Contributions from noncontrolling interests

     

    2,040

     

     

     

    —

     

    Issuance of common stock, net

     

    188,350

     

     

     

    71,362

     

    Dividends paid on common stock

     

    (214,692

    )

     

     

    (209,174

    )

    Net cash provided by (used in) financing activities

     

    141,652

     

     

     

    (80,597

    )

    Net increase in cash, cash equivalents and restricted cash

     

    141,424

     

     

     

    22,415

     

    Effect of foreign currency translation on cash, cash equivalents and restricted cash

     

    (245

    )

     

     

    (158

    )

    Cash, cash equivalents and restricted cash, beginning of period

     

    66,339

     

     

     

    46,719

     

    Cash, cash equivalents and restricted cash, end of period

    $

    207,518

     

     

    $

    68,976

     

    Supplemental disclosure of cash flow information:

     

     

     

    Interest paid

    $

    72,820

     

     

    $

    71,632

     

     

    SABRA HEALTH CARE REIT, INC.

    FUNDS FROM OPERATIONS (FFO), NORMALIZED FFO,

    ADJUSTED FUNDS FROM OPERATIONS (AFFO) AND NORMALIZED AFFO

    (dollars in thousands, except per share data)

     

     

    Three Months Ended September 30,

     

    Nine Months Ended September 30,

     

     

    2025

     

     

     

    2024

     

     

     

    2025

     

     

     

    2024

     

    Net income attributable to Sabra Health Care REIT, Inc.

    $

    22,538

     

     

    $

    29,788

     

     

    $

    128,384

     

     

    $

    80,017

     

    Add:

     

     

     

     

     

     

     

    Depreciation and amortization of real estate assets

     

    48,511

     

     

     

    42,720

     

     

     

    135,591

     

     

     

    127,315

     

    Depreciation and amortization of real estate assets related to noncontrolling interests

     

    (40

    )

     

     

    —

     

     

     

    (40

    )

     

     

    —

     

    Depreciation and amortization of real estate assets related to unconsolidated joint ventures

     

    1,722

     

     

     

    2,243

     

     

     

    5,945

     

     

     

    6,680

     

    Net loss (gain) on sales of real estate

     

    4,430

     

     

     

    5,745

     

     

     

    (5,544

    )

     

     

    3,969

     

    Impairment of real estate

     

    2,571

     

     

     

    —

     

     

     

    6,674

     

     

     

    18,472

     

    FFO attributable to Sabra Health Care REIT, Inc.

    $

    79,732

     

     

    $

    80,496

     

     

    $

    271,010

     

     

    $

    236,453

     

    Write-offs of cash and straight-line rental income receivable and lease intangibles

     

    9,237

     

     

     

    3,086

     

     

     

    7,759

     

     

     

    5,539

     

    Lease termination income, net of expense

     

    (1,518

    )

     

     

    —

     

     

     

    (1,518

    )

     

     

    —

     

    Loss on extinguishment of debt

     

    1,154

     

     

     

    —

     

     

     

    1,154

     

     

     

    —

     

    Recovery of loan losses

     

    (240

    )

     

     

    (148

    )

     

     

    (640

    )

     

     

    (446

    )

    Other normalizing items (1)

     

    270

     

     

     

    119

     

     

     

    (14,166

    )

     

     

    2,718

     

    Normalized FFO attributable to Sabra Health Care REIT, Inc.

    $

    88,635

     

     

    $

    83,553

     

     

    $

    263,599

     

     

    $

    244,264

     

    FFO attributable to Sabra Health Care REIT, Inc.

    $

    79,732

     

     

    $

    80,496

     

     

    $

    271,010

     

     

    $

    236,453

     

    Stock-based compensation expense

     

    2,875

     

     

     

    2,586

     

     

     

    8,290

     

     

     

    6,448

     

    Non-cash rental and related revenues

     

    7,151

     

     

     

    (433

    )

     

     

    820

     

     

     

    (2,229

    )

    Non-cash interest expense

     

    2,153

     

     

     

    2,611

     

     

     

    5,608

     

     

     

    8,750

     

    Non-cash portion of loss on extinguishment of debt

     

    (1,730

    )

     

     

    —

     

     

     

    (1,730

    )

     

     

    —

     

    Recovery of loan losses

     

    (240

    )

     

     

    (148

    )

     

     

    (640

    )

     

     

    (446

    )

    Other adjustments related to unconsolidated joint ventures

     

    218

     

     

     

    113

     

     

     

    237

     

     

     

    401

     

    Other adjustments (2)

     

    547

     

     

     

    365

     

     

     

    (15,535

    )

     

     

    1,216

     

    AFFO attributable to Sabra Health Care REIT, Inc.

    $

    90,706

     

     

    $

    85,590

     

     

    $

    268,060

     

     

    $

    250,593

     

    Lease termination income, net of expense

     

    (1,518

    )

     

     

    —

     

     

     

    (1,518

    )

     

     

    —

     

    Cash portion of loss on extinguishment of debt

     

    2,884

     

     

     

    —

     

     

     

    2,884

     

     

     

    —

     

    Write-off of cash rental income

     

    —

     

     

     

    1,189

     

     

     

    —

     

     

     

    751

     

    Other normalizing items (1)

     

    81

     

     

     

    113

     

     

     

    2,619

     

     

     

    2,549

     

    Normalized AFFO attributable to Sabra Health Care REIT, Inc.

    $

    92,153

     

     

    $

    86,892

     

     

    $

    272,045

     

     

    $

    253,893

     

    Amounts per diluted common share attributable to Sabra Health Care REIT, Inc.:

     

     

     

     

     

     

     

    Net income

    $

    0.09

     

     

    $

    0.13

     

     

    $

    0.53

     

     

    $

    0.34

     

    FFO

    $

    0.33

     

     

    $

    0.34

     

     

    $

    1.12

     

     

    $

    1.01

     

    Normalized FFO

    $

    0.36

     

     

    $

    0.35

     

     

    $

    1.09

     

     

    $

    1.04

     

    AFFO

    $

    0.37

     

     

    $

    0.36

     

     

    $

    1.10

     

     

    $

    1.06

     

    Normalized AFFO

    $

    0.38

     

     

    $

    0.37

     

     

    $

    1.12

     

     

    $

    1.08

     

    Weighted average number of common shares outstanding, diluted:

     

     

     

     

     

     

    Net income, FFO and Normalized FFO

     

    243,558,449

     

     

     

    237,043,400

     

     

     

    241,593,992

     

     

     

    234,777,101

     

    AFFO and Normalized AFFO

     

    244,468,871

     

     

     

    237,940,868

     

     

     

    242,666,745

     

     

     

    235,890,966

     

    (1)

    Other normalizing items for FFO for the nine months ended September 30, 2025 include a $17.2 million gain reclassified from other comprehensive loss related to six previously terminated interest rate swaps as the related forecasted transactions were determined to be probable not to occur and $3.4 million of transition expenses related to the transition of Senior Housing - Managed communities to new operators. Other normalizing items for AFFO for the nine months ended September 30, 2025 include $3.4 million of transition expenses related to the transition of Senior Housing - Managed communities to new operators. In addition, other normalizing items for FFO and AFFO include triple-net operating expenses, net of recoveries.

    (2)

    Other adjustments for the nine months ended September 30, 2025 include a $17.2 million gain reclassified from other comprehensive loss related to six terminated interest rate swaps as the related forecasted transactions were determined to be probable not to occur.

    Adjusted EBITDA*

    Adjusted EBITDA is calculated as earnings before interest, taxes, depreciation and amortization ("EBITDA") excluding the impact of merger-related costs, stock-based compensation expense under the Company's long-term equity award program, and loan loss reserves. Adjusted EBITDA is an important non-GAAP supplemental measure of operating performance.

    Behavioral Health

    Includes behavioral hospitals that provide inpatient and outpatient care for patients with mental health conditions, chemical dependence or substance addictions and addiction treatment centers that provide treatment services for chemical dependence and substance addictions, which may include inpatient care, outpatient care, medical detoxification, therapy and counseling.

    Cash Net Operating Income ("Cash NOI")*

    The Company believes that net income as defined by GAAP is the most appropriate earnings measure. The Company considers Cash NOI an important supplemental measure because it allows investors, analysts and its management to evaluate the operating performance of its investments. The Company defines Cash NOI as total revenues less operating expenses and non-cash revenues and expenses. Cash NOI excludes all other financial statement amounts included in net income and is presented at Sabra's pro rata share.

    EBITDARM

    Earnings before interest, taxes, depreciation, amortization, rent and management fees ("EBITDARM") for a particular facility accruing to the operator/tenant of the property (not the Company), for the period presented. The Company uses EBITDARM in determining EBITDARM Coverage. EBITDARM has limitations as an analytical tool. EBITDARM does not reflect historical cash expenditures or future cash requirements for facility capital expenditures or contractual commitments. In addition, EBITDARM does not represent a property's net income or cash flows from operations and should not be considered an alternative to those indicators. The Company utilizes EBITDARM to evaluate the core operations of the properties by eliminating management fees, which may vary by operator/tenant and operating structure, and as a supplemental measure of the ability of the Company's operators/tenants and relevant guarantors to generate sufficient liquidity to meet related obligations to the Company.

    EBITDARM Coverage

    Represents the ratio of EBITDARM to cash rent for owned facilities (excluding Senior Housing - Managed communities) for the period presented. EBITDARM Coverage is a supplemental measure of a property's ability to generate cash flows for the operator/tenant (not the Company) to meet the operator's/tenant's related cash rent and other obligations to the Company. However, its usefulness is limited by, among other things, the same factors that limit the usefulness of EBITDARM. EBITDARM Coverage includes only Stabilized Facilities and excludes facilities for which data is not available or meaningful.

    Funds From Operations ("FFO") and Adjusted Funds from Operations ("AFFO")*

    The Company believes that net income as defined by GAAP is the most appropriate earnings measure. The Company also believes that funds from operations, or FFO, as defined in accordance with the definition used by the National Association of Real Estate Investment Trusts ("Nareit"), and adjusted funds from operations, or AFFO (and related per share amounts) are important non-GAAP supplemental measures of the Company's operating performance. Because the historical cost accounting convention used for real estate assets requires straight-line depreciation (except on land), such accounting presentation implies that the value of real estate assets diminishes predictably over time. However, since real estate values have historically risen or fallen with market and other conditions, presentations of operating results for a real estate investment trust that uses historical cost accounting for depreciation could be less informative. Thus, Nareit created FFO as a supplemental measure of operating performance for real estate investment trusts that excludes historical cost depreciation and amortization, among other items, from net income, as defined by GAAP. FFO is defined as net income, computed in accordance with GAAP, excluding gains or losses from real estate dispositions and the Company's share of gains or losses from real estate dispositions related to its unconsolidated joint ventures, plus real estate depreciation and amortization, net of amounts related to noncontrolling interests, plus the Company's share of depreciation and amortization related to its unconsolidated joint ventures, and real estate impairment charges of both consolidated and unconsolidated entities when the impairment is directly attributable to decreases in the value of depreciable real estate held by the entity. AFFO is defined as FFO excluding stock-based compensation expense, non-cash rental and related revenues, non-cash interest income, non-cash interest expense, non-cash portion of loss on extinguishment of debt, provision for (recovery of) loan losses and other reserves, non-cash lease termination income and deferred income taxes, as well as other non-cash revenue and expense items (including noncapitalizable acquisition costs, transaction costs related to operator transitions and organizational or other restructuring activities, gain/loss on derivative instruments, and non-cash revenue and expense amounts related to noncontrolling interests) and the Company's share of non-cash adjustments related to its unconsolidated joint ventures. The Company believes that the use of FFO and AFFO (and the related per share amounts), combined with the required GAAP presentations, improves the understanding of the Company's operating results among investors and makes comparisons of operating results among real estate investment trusts more meaningful. The Company considers FFO and AFFO to be useful measures for reviewing comparative operating and financial performance because, by excluding the applicable items listed above, FFO and AFFO can help investors compare the operating performance of the Company between periods or as compared to other companies. While FFO and AFFO are relevant and widely used measures of operating performance of real estate investment trusts, they do not represent cash flows from operations or net income as defined by GAAP and should not be considered an alternative to those measures in evaluating the Company's liquidity or operating performance. FFO and AFFO also do not consider the costs associated with capital expenditures related to the Company's real estate assets nor do they purport to be indicative of cash available to fund the Company's future cash requirements. Further, the Company's computation of FFO and AFFO may not be comparable to FFO and AFFO reported by other real estate investment trusts that do not define FFO in accordance with the current Nareit definition or that interpret the current Nareit definition or define AFFO differently than the Company does.

    Investment

    Represents the carrying amount of real estate assets after adding back accumulated depreciation and amortization and excludes net intangible assets and liabilities.

    Net Debt*

    The principal balances of the Company's revolving credit facility, term loans, senior unsecured notes, and secured indebtedness as reported in the Company's consolidated financial statements, net of cash and cash equivalents as reported in the Company's consolidated financial statements.

    Net Debt to Adjusted EBITDA*

    Net Debt to Adjusted EBITDA is calculated as Net Debt divided by Annualized Adjusted EBITDA, which is Adjusted EBITDA, as adjusted for annualizing adjustments that give effect to the acquisitions and dispositions completed during the respective period as though such acquisitions and dispositions were completed as of the beginning of the period presented.

    Net Operating Income ("NOI")*

    The Company believes that net income as defined by GAAP is the most appropriate earnings measure. The Company considers NOI an important supplemental measure because it allows investors, analysts and its management to evaluate the operating performance of its investments. The Company defines NOI as total revenues less operating expenses. NOI excludes all other financial statement amounts included in net income.

    Normalized FFO and Normalized AFFO*

    Normalized FFO and Normalized AFFO represent FFO and AFFO, respectively, adjusted for certain income and expense items that the Company does not believe are indicative of its ongoing operating results. The Company considers Normalized FFO and Normalized AFFO to be useful measures to evaluate the Company's operating results excluding these income and expense items to help investors compare the operating performance of the Company between periods or as compared to other companies. Normalized FFO and Normalized AFFO do not represent cash flows from operations or net income as defined by GAAP and should not be considered an alternative to those measures in evaluating the Company's liquidity or operating performance. Normalized FFO and Normalized AFFO also do not consider the costs associated with capital expenditures related to the Company's real estate assets nor do they purport to be indicative of cash available to fund the Company's future cash requirements. Further, the Company's computation of Normalized FFO and Normalized AFFO may not be comparable to Normalized FFO and Normalized AFFO reported by other real estate investment trusts that do not define FFO in accordance with the current Nareit definition or that interpret the current Nareit definition or define FFO and AFFO or Normalized FFO and Normalized AFFO differently than the Company does.

    Senior Housing

    Senior Housing communities include independent living, assisted living, continuing care retirement and memory care communities.

    Senior Housing - Managed

    Senior Housing communities operated by third-party property managers pursuant to property management agreements.

    Skilled Nursing/Transitional Care

    Skilled Nursing/Transitional Care facilities include skilled nursing, transitional care, multi-license designation and mental health facilities.

    Specialty Hospitals and Other

    Includes acute care, long-term acute care and rehabilitation hospitals, facilities that provide residential services, which may include assistance with activities of daily living, and other facilities not classified as Skilled Nursing/Transitional Care, Senior Housing or Behavioral Health.

    Stabilized Facility

    At the time of acquisition, the Company classifies each facility as either stabilized or non-stabilized. In addition, the Company may classify a facility as non-stabilized after acquisition. Circumstances that could result in a facility being classified as non-stabilized include newly completed developments, facilities undergoing major renovations or additions, facilities being repositioned or transitioned to new operators, and significant transitions within the tenants' business model. Such facilities are typically reclassified to stabilized upon the earlier of maintaining consistent performance or 24 months after the date of classification as non-stabilized. Stabilized Facilities generally exclude (i) facilities held for sale, (ii) strategic disposition candidates, (iii) facilities being transitioned to a new operator, (iv) facilities being transitioned from being leased by the Company to being operated by the Company and (v) leased facilities acquired during the three months preceding the period presented.

    *Non-GAAP Financial Measures

    Reconciliations, definitions and important discussions regarding the usefulness and limitations of the Non-GAAP Financial Measures used in this release can be found at https://ir.sabrahealth.com/investors/financials/quarterly-results.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20251105750725/en/

    Investor & Media Inquiries: (888) 393-8248 or [email protected]

    Get the next $SBRA alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SBRA

    DatePrice TargetRatingAnalyst
    10/1/2025$20.00Neutral
    Cantor Fitzgerald
    1/17/2025Buy → Hold
    Truist
    1/7/2025$20.00Mkt Perform → Mkt Outperform
    JMP Securities
    12/5/2024$20.00Outperform → Neutral
    Mizuho
    10/1/2024$16.00 → $20.00Equal Weight → Overweight
    Wells Fargo
    9/13/2024$17.00 → $20.00Neutral → Buy
    Citigroup
    1/30/2024$21.00Buy
    Deutsche Bank
    10/17/2023$16.00Outperform → Market Perform
    BMO Capital Markets
    More analyst ratings

    $SBRA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Malehorn Jeffrey A. was granted 813 shares, increasing direct ownership by 0.78% to 105,630 units (SEC Form 4)

    4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)

    9/3/25 2:14:32 PM ET
    $SBRA
    Real Estate Investment Trusts
    Real Estate

    Director Kono Ann was granted 887 shares, increasing direct ownership by 2% to 57,396 units (SEC Form 4)

    4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)

    9/3/25 2:14:20 PM ET
    $SBRA
    Real Estate Investment Trusts
    Real Estate

    Director Katzmann Lynne S was granted 813 shares, increasing direct ownership by 1% to 75,405 units (SEC Form 4)

    4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)

    9/3/25 2:12:51 PM ET
    $SBRA
    Real Estate Investment Trusts
    Real Estate

    $SBRA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Sabra Reports Third Quarter 2025 Results; Updates 2025 Guidance

    Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced its results of operations for the third quarter of 2025. THIRD QUARTER 2025 RESULTS AND RECENT EVENTS Results per diluted common share for the third quarter of 2025 were as follows: Net Income: $0.09 FFO: $0.33 Normalized FFO: $0.36 AFFO: $0.37 Normalized AFFO: $0.38 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 2.35x Senior Housing - Leased: 1.52x Behavioral Health, Specialty Hospitals and Other: 3.90x Same store managed senior housing Cash NOI increased 13.3% on a year-over-year basis. Excluding the 16 properties formerly operated by Holiday that remain in

    11/5/25 4:05:00 PM ET
    $SBRA
    Real Estate Investment Trusts
    Real Estate

    Sabra Health Care REIT, Inc. Announces Third Quarter 2025 Earnings Release Date and Conference Call

    Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that it will issue its 2025 third quarter earnings release on November 5, 2025, after the close of trading. A conference call with a simultaneous webcast to discuss the 2025 third quarter results will be held on Thursday, November 6th at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID number is 1382596. The webcast URL is https://events.q4inc.com/attendee/285294519. A digital replay of the call will be available on our website at www.sabrahealth.com. About Sabra Sabra Health Care REIT, Inc., a Maryland

    10/22/25 4:05:00 PM ET
    $SBRA
    Real Estate Investment Trusts
    Real Estate

    Sabra Health Care REIT, Inc. to Attend the AHCA/NCAL Convention & Expo

    Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that Talya Nevo-Hacohen, the company's Chief Investment Officer, Kara Pappanduros, the company's Senior Vice President of Asset Management, and other members of the company, will attend the AHCA/NCAL Convention & Expo, Delivering Solutions 25 on October 19-22, 2025, at the South Convention Center of the Mandalay Bay Resort & Casino in Las Vegas, Nevada. Ms. Nevo-Hacohen will participate in an Investment Solutions panel on October 21st. About Sabra Sabra Health Care REIT, Inc., a Maryland corporation, operates as a self-administered, self-managed real estate investment trust (a "REIT") that, through its subsidiaries, owns and inv

    10/6/25 4:05:00 PM ET
    $SBRA
    Real Estate Investment Trusts
    Real Estate

    $SBRA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Cusack Catherine bought $40,315 worth of shares (2,500 units at $16.13), increasing direct ownership by 4% to 60,583 units (SEC Form 4)

    4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)

    2/25/25 5:04:04 PM ET
    $SBRA
    Real Estate Investment Trusts
    Real Estate

    Cusack Catherine bought $101,010 worth of shares (7,000 units at $14.43), increasing direct ownership by 18% to 46,385 units (SEC Form 4)

    4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)

    5/23/24 7:00:45 PM ET
    $SBRA
    Real Estate Investment Trusts
    Real Estate

    $SBRA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Cantor Fitzgerald initiated coverage on Sabra Health Care REIT with a new price target

    Cantor Fitzgerald initiated coverage of Sabra Health Care REIT with a rating of Neutral and set a new price target of $20.00

    10/1/25 9:38:36 AM ET
    $SBRA
    Real Estate Investment Trusts
    Real Estate

    Sabra Health Care REIT downgraded by Truist

    Truist downgraded Sabra Health Care REIT from Buy to Hold

    1/17/25 11:05:39 AM ET
    $SBRA
    Real Estate Investment Trusts
    Real Estate

    Sabra Health Care REIT upgraded by JMP Securities with a new price target

    JMP Securities upgraded Sabra Health Care REIT from Mkt Perform to Mkt Outperform and set a new price target of $20.00

    1/7/25 8:27:55 AM ET
    $SBRA
    Real Estate Investment Trusts
    Real Estate

    $SBRA
    SEC Filings

    View All

    SEC Form 10-Q filed by Sabra Health Care REIT Inc.

    10-Q - Sabra Health Care REIT, Inc. (0001492298) (Filer)

    11/5/25 4:09:31 PM ET
    $SBRA
    Real Estate Investment Trusts
    Real Estate

    Sabra Health Care REIT Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Sabra Health Care REIT, Inc. (0001492298) (Filer)

    11/5/25 4:06:01 PM ET
    $SBRA
    Real Estate Investment Trusts
    Real Estate

    Amendment: SEC Form SCHEDULE 13G/A filed by Sabra Health Care REIT Inc.

    SCHEDULE 13G/A - Sabra Health Care REIT, Inc. (0001492298) (Subject)

    8/11/25 5:32:02 PM ET
    $SBRA
    Real Estate Investment Trusts
    Real Estate

    $SBRA
    Leadership Updates

    Live Leadership Updates

    View All

    Sabra Health Care REIT Appoints Jessica Flores as Chief Accounting Officer

    Sabra Health Care REIT, Inc. ("Sabra") (NASDAQ:SBRA) today announced that Jessica Flores has been appointed Executive Vice President and Chief Accounting Officer and, in such capacity, has been designated by the Company's Board of Directors as the Company's principal accounting officer. Ms. Flores currently serves as Sabra's Senior Vice President – Finance and Controller, a position she has held since January 2022. Ms. Flores joined Sabra in March 2011 and held various leadership positions overseeing Sabra's accounting during that time. Ms. Flores has over 15 years of experience in accounting, finance and real estate investments, having previously worked for KBS Realty Advisors and Deloit

    1/4/24 9:15:00 AM ET
    $SBRA
    Real Estate Investment Trusts
    Real Estate

    Sabra Health Care REIT Appoints Katie Cusack to its Board of Directors

    IRVINE, Calif.--(BUSINESS WIRE)--Sabra Health Care REIT, Inc. (“Sabra”) (Nasdaq: SBRA) today announced the appointment of Katie Cusack to its Board of Directors. Ms. Cusack currently serves as Chief Operating Officer of Cornell Capital LLC, a $4 billion private investment firm with offices in New York and Hong Kong. From 2007 to 2020, Ms. Cusack served in various capacities at Credit Suisse, including Chief Operating Officer for the Investment Banking Division in both Asia Pacific and Europe, Middle East and Africa, and as the Head of Ultra-High Net Worth Coverage. Prior to joining Credit Suisse, Ms. Cusack served as a Managing Director at MTS Health Partners LP, where she provided

    1/12/21 9:05:00 AM ET
    $SBRA
    Real Estate Investment Trusts
    Real Estate

    Sabra Health Care REIT Appoints Ann Kono to Board of Directors

    IRVINE, Calif.--(BUSINESS WIRE)--Sabra Health Care REIT, Inc. (“Sabra”) (Nasdaq: SBRA) today announced the appointment of Ann Kono to its Board of Directors. Ms. Kono currently serves as the chief executive officer of Leda Advisory Group, a management consulting firm she founded in January 2019 that partners with startup companies to advise on growth and scale. Prior to founding Leda, Ms. Kono spent 11 years at Ares Management Corporation, where she held the position of Chief Information and Risk Officer, and oversaw Operational, Investment and Enterprise Risks. Ms. Kono also serves on the board of directors of Stable Road Acquisition Company, a position she has held since 2019. M

    12/21/20 9:00:00 AM ET
    $SBRA
    Real Estate Investment Trusts
    Real Estate

    $SBRA
    Financials

    Live finance-specific insights

    View All

    Sabra Reports Third Quarter 2025 Results; Updates 2025 Guidance

    Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced its results of operations for the third quarter of 2025. THIRD QUARTER 2025 RESULTS AND RECENT EVENTS Results per diluted common share for the third quarter of 2025 were as follows: Net Income: $0.09 FFO: $0.33 Normalized FFO: $0.36 AFFO: $0.37 Normalized AFFO: $0.38 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 2.35x Senior Housing - Leased: 1.52x Behavioral Health, Specialty Hospitals and Other: 3.90x Same store managed senior housing Cash NOI increased 13.3% on a year-over-year basis. Excluding the 16 properties formerly operated by Holiday that remain in

    11/5/25 4:05:00 PM ET
    $SBRA
    Real Estate Investment Trusts
    Real Estate

    Sabra Health Care REIT, Inc. Announces Third Quarter 2025 Earnings Release Date and Conference Call

    Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that it will issue its 2025 third quarter earnings release on November 5, 2025, after the close of trading. A conference call with a simultaneous webcast to discuss the 2025 third quarter results will be held on Thursday, November 6th at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID number is 1382596. The webcast URL is https://events.q4inc.com/attendee/285294519. A digital replay of the call will be available on our website at www.sabrahealth.com. About Sabra Sabra Health Care REIT, Inc., a Maryland

    10/22/25 4:05:00 PM ET
    $SBRA
    Real Estate Investment Trusts
    Real Estate

    Sabra Reports Second Quarter 2025 Results; Updates 2025 Guidance

    Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced its results of operations for the second quarter of 2025. SECOND QUARTER 2025 RESULTS AND RECENT EVENTS Results per diluted common share for the second quarter of 2025 were as follows: Net Income: $0.27 FFO: $0.44 Normalized FFO: $0.37 AFFO: $0.37 Normalized AFFO: $0.38 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 2.27x Senior Housing - Leased: 1.49x Behavioral Health, Specialty Hospitals and Other: 3.87x Same store managed senior housing Cash NOI increased 17.1% on a year-over-year basis. In the second quarter of 2025, Sabra acquired a mana

    8/4/25 4:05:00 PM ET
    $SBRA
    Real Estate Investment Trusts
    Real Estate

    $SBRA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Sabra Health Care REIT Inc.

    SC 13G/A - Sabra Health Care REIT, Inc. (0001492298) (Subject)

    10/18/24 11:35:05 AM ET
    $SBRA
    Real Estate Investment Trusts
    Real Estate

    SEC Form SC 13G/A filed by Sabra Health Care REIT Inc. (Amendment)

    SC 13G/A - Sabra Health Care REIT, Inc. (0001492298) (Subject)

    2/13/24 5:13:53 PM ET
    $SBRA
    Real Estate Investment Trusts
    Real Estate

    SEC Form SC 13G/A filed by Sabra Health Care REIT Inc. (Amendment)

    SC 13G/A - Sabra Health Care REIT, Inc. (0001492298) (Subject)

    2/13/24 2:19:42 PM ET
    $SBRA
    Real Estate Investment Trusts
    Real Estate